ClinVar Miner

Submissions for variant NM_000252.3(MTM1):c.1644+1G>A

dbSNP: rs398123272
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Congenital Myopathies Variant Curation Expert Panel, ClinGen RCV001196667 SCV005367897 pathogenic Severe X-linked myotubular myopathy 2024-08-07 reviewed by expert panel curation The NM_000252.3:c.1644+1G>A variant in MTM1 occurs within the canonical splice donor site (+1) of intron 14. Although the exact impact of this variant on splicing is unknown, it might cause skipping of biologically-relevant-exon 14/15 resulting in an in-frame deletion and escape nonsense mediated decay, removing <10% of the protein based on computational predictions. However, the C-terminus of MTM1 is a critical region to protein function as specified by the ClinGen Congenital Myopathy VCEP, thus meeting PVS1_Strong. The variant is absent from gnomAD v4.1.0 meeting PM2_Supporting. This variant has been detected in 3 individuals with myotubular myopathy (PS4_Moderate, PMID:28685322, 33062893, 34366366), one of which has been identified as a de novo occurrence with confirmed parental relationships whose muscle biopsy showed central nuclei, necklace fibers, and atrophy fibers which is highly specific for the disease (PS2, PP4, PMID:28685322). In summary, this variant meets the criteria to be classified as pathogenic for X-linked centronuclear myopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: PVS1_Strong, PS2, PS4_Moderate, PP4, PM2_Supporting (ClinGen Congenital Myopathies VCEP specifications version 1; 8/7/2024).
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV001196667 SCV001367298 pathogenic Severe X-linked myotubular myopathy 2019-10-01 criteria provided, single submitter clinical testing This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5. This variant was detected in hemizygous state.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.